lobbying_activities: 2102317
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2102317 | 02cf6776-d9d7-4ba4-9b0e-7aeb4ce75dea | Q1 | GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION) | 40049384 | GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION) | 2018 | first_quarter | MMM | (i) BiPartisan Budget Act of 2018, Title II Medicare Extenders especially Sec 50202 Medicare part B therapy cap repeal; and specific issues in Title X, Titles XI and Title XII (ii) Omnibus Appropriations Act of 2018 unsuccessful efforts to clarify SNF use of concurrent and group therapies; (iii) CMS FY19 SNF PPS proposed rule making; (iv) CMS Advanced Notice of proposed rule-making SNF PPS Payment Methodology, and (vi) CMS implementation of quality measures/IMPACT Act provisions | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 86000 | 0 | 0 | 2018-04-05T17:30:20.697000-04:00 |